As the landscape of biotherapies continues to evolve, pharmacies are increasingly positioned to play a crucial role in the delivery and management of cell and gene therapy products.
10 min read |Open Access |Feature
The Power of Unity: We are in this together.
3 min read |Members Only |President’s Message
Advanced cell and gene therapies are transforming medicine, offering new hope for patients with diseases once considered untreatable.
5 min read |Members Only |Feature
CART T-cell therapy recipient Sonia Su shares her journey as a three-time cancer survivor and the life-changing impact of immunotherapy.
7 min read |Members Only |Feature
Foundation Scholar Recipient's Research Investigates Ways to Extend the Duration of Gene-Edited HSCs.
5 min read |Open Access |AABB Foundation: Shaping the Industry
In this month’s “In Conversation” interview, Mark Sawicki, PhD, president and CEO of Cryoport Systems, discusses critical challenges facing the cell and gene therapy field and cutting-edge solutions to safeguard CGT products.
7 min read |Members Only |In Conversation
Maria De Los Angeles Muñiz, MD, discusses translating critical information to improve global access and her passion to educate the next generation of Puerto Rican leaders in the field.
6 min read |Open Access |White Coats
Of Note: News stories from the field.
4 min read |Members Only |Of Note
AABB Volunteer Spotlight: Meet Justin Halls, MD, MPH
2 min read |Members Only |Membership Focus
In the Meet Our Consultant series, Jennifer Chain, PhD, CABP, discusses her consulting journey with AABB and offers tips for emerging biotherapies professionals.
5 min read |Open Access |In Conversation
Breaking the cycle of living paycheck to paycheck requires a strategic approach. By implementing the right financial habits, you can achieve financial stability and gain control over your money.
5 min read |Members Only |Be Well
Transfusion is AABB’s scholarly, peer-reviewed monthly journal, publishing the latest on technological advances, clinical research and controversial issues related to transfusion medicine, blood banking, biotherapies and tissue transplantation. Access of Transfusion is free to all AABB members.
Learn More About Transfusion Journal
Keep abreast of what's happening in the field of biotherapies with CellSource - AABB's monthly update on the latest biotherapies news.
To submit news about the blood and biotherapies field to AABB, please email news@aabb.org.
President
Meghan Delaney, DO, MPH
Chief Executive Officer
Debra Ben Avram, FASAE, CAE
Chief Communications and Engagement
Officer Julia Zimmerman
Director of Marketing and Communications
Jay Lewis, MPH
Managing Editor
Kendra Y. Mims, MFA
Senior Communications Manager
Drew Case
AABB News
(ISSN 1523939X) is published monthly, except for the combined November/December issue for the members of AABB; 4550 Montgomery Avenue; Suite 700 North Tower; Bethesda, MD 20814.
AABB is an international, not-for-profit association representing individuals and institutions involved in transfusion medicine, cellular therapies and patient blood management. The association is committed to improving health by developing and delivering standards, accreditation and educational programs that focus on optimizing patient and donor care and safety.
+1.301.907.6977
Email: news@aabb.org
Website: www.aabb.org
Copyright 2025 by AABB.
Views and opinions expressed in AABB News are not necessarily endorsed by AABB unless expressly stated.
Notice to Copiers: Reproduction in whole or part is strictly prohibited unless written permission has been granted by the publisher. AABB members need not obtain prior permission if proper credit is given.
4550 Montgomery Avenue
Suite 700, North Tower
Bethesda, MD 20814
301.907.6977
